Principal Scientist, CDx IHC Development
Core
Lead the end-to-end development of immunohistochemistry (IHC) companion diagnostics (CDx) assays and kits for oncology drug programs, from early feasibility through regulatory submission and commercialization readiness.
Role type
Principal Scientist, CDx IHC Development
Builds
IVD-ready CDx IHC assays and kits for oncology therapeutics
Domain
Biopharmaceuticals / Oncology / In Vitro Diagnostics
Required skills
IHC assay development, analytical validation, design control, QMS (21 CFR Part 820, ISO 13485), regulatory submissions (FDA, NMPA, IVDR), biomarker strategy, cross-functional leadership
Preferred skills
Late-stage CDx program experience, oncology biomarker background (NSCLC, GI), health authority interaction
Technologies
Ventana, Dako, Leica
Responsibilities
Define assay design and platform selection; oversee antibody selection and assay optimization; lead analytical validation strategy and execution; ensure compliance with global regulatory standards; support clinical trial implementation and central lab alignment; partner with Regulatory Affairs and QA for submissions; mentor team members
Seniority
Principal, hands-on scientific leadership